Position in NVO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,127,165
+$263,099 QoQ
Shares Held
23,512
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#501
of 1,348 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hikari Tsushin, Inc. holds $60,254,195 across 7 Drug Manufacturers - General names. NVO ranks #5 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
109,067 | $27,699,745 | |
| 2 | ABBV |
AbbVie Inc.
|
101,443 | $25,527,116 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
81,141 | $4,675,344 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,812 | $1,132,342 | |
| 5 | NVO |
Novo Nordisk A S
This page
|
23,512 | $1,127,165 | |
| 6 | AMGN |
Amgen Inc
|
233 | $84,373 | |
| 7 | OGN |
Organon & Co.
|
599 | $8,110 |
All Filings in NVO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,127,165 | 23,512 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $864,066 | 23,512 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,196,290 | 23,512 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $1,304,680 | 23,512 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,622,798 | 23,512 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,632,673 | 23,512 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,022,502 | 23,512 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,799,573 | 23,512 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,356,102 | 23,512 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $3,018,940 | 23,512 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $2,432,316 | 23,512 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $6,180,918 | 67,967 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $10,190,435 | 62,970 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $10,021,045 | 62,970 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $8,522,359 | 62,970 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $6,273,701 | 62,970 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $7,016,747 | 62,970 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $6,992,818 | 62,970 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $7,052,640 | 62,970 | Shares | Sole | 2022-02-08 | |
| 2021-06-30 | $5,274,996 | 62,970 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $4,245,437 | 62,970 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $4,398,454 | 62,970 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $4,372,007 | 62,970 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,123,275 | 62,970 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,790,794 | 62,970 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||